12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Longeveron (NASDAQ:LGVN) stock rose 30.9% to $2.37 during Thursday’s pre-market session. The company’s market cap stands at…
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 27.8% to $0.58 during Wednesday’s regular session. The company’s market…
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Onconetix (NASDAQ:ONCO) stock increased by 152.6% to $0.37 during Thursday’s pre-market session. The market value of their…
Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, but issued FY24 EPS guidance below estimates.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) shares moved upwards by 46.5% to $1.67 during Tuesday’s regular session. The market value…
Catheter Precision And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by over 100 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Tilray Brands And 2 Other Penny Stocks Insiders Are Buying
The Dow Jones index closed higher by over 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Cather Precision, Inc.’s Board Authorizes Its CEO And Chairman To Purchase 500K Shares Of Company Common Stock In Open Market Transactions
Catheter Precision, Inc. (the "Company") (NYSE:VTAK), an innovative US-based medical device Company dedicated to improving the lives of patients with cardiac arrhythmias, announces that its CEO and Chairman, Mr. David
CATHETER PRECISION, INC. Reports Unaudited Preliminary Q4 And FY23 Results; Sees Q4 Revenue $129K.; FY23 Revenue $442K
Catheter Precision, Inc. (VTAK:NYSE/American) an innovative US-based medical device Company dedicated to improving the lives of patients with cardiac arrhythmias, announced corporate highlights and unaudited preliminary
Catheter Precision’s First Successful VIVO Cases Completed In Croatia Sets Stage For Expansion Into South-Eastern Europe
Catheter Precision, Inc. (the "Company") (NYSE:VTAK), a pioneering medical technology firm headquartered in the United States, specializing in electrophysiology devices, has proudly disclosed the successful conclusion of